Searching map area
Regorafenib
? TBD
Chemical compound
Join to rate
Join to rate

Regorafenib, sold under the brand name Stivarga among others, is an oral multi-kinase inhibitor developed by Bayer which targets angiogenic, stromal and oncogenic receptor tyrosine kinase (RTK). Regorafenib shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition. Since 2009 it was studied as a potential...

Instance of
type of chemical entity
Subclass of
Chemical compound
Wikidata